Диссертация (1145852), страница 17
Текст из файла (страница 17)
№ 25. — C. 3143-421.122. Nofer J.R., Remaley A.T. Tangier disease: still more questions than answers// Cell Mol Life Sci. 2005. Т. 62. № 19-20. — C. 2150-60.123. Ono K. Current concept of reverse cholesterol transport and novel strategyfor atheroprotection // J Cardiol. 2012.
Т. 60. № 5. — C. 339-43.124. Oosterveer M.H., Grefhorst A., Groen A.K., Kuipers F. The liver X receptor:control of cellular lipid homeostasis and beyond Implications for drug design // Prog LipidRes. 2010. Т. 49. № 4. — C. 343-52.108125. Oram J.F. ATP-binding cassette transporter A1 and cholesterol trafficking //Curr Opin Lipidol. 2002. Т. 13. № 4. — C. 373-81.126. Oram J.F. HDL apolipoproteins and ABCA1: partners in the removal ofexcess cellular cholesterol // Arterioscler Thromb Vasc Biol. 2003. Т. 23. № 5. — C.
7207.127. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cellcholesterol exporter that protects against cardiovascular disease // Physiol Rev. 2005. Т.85. № 4. — C. 1343-72.128. Oram J.F., Lawn R.M., Garvin M.R., Wade D.P. ABCA1 is the cAMPinducible apolipoprotein receptor that mediates cholesterol secretion from macrophages// J Biol Chem. 2000. Т. 275. № 44.
— C. 34508-11.129. Porchay-Balderelli I., Pean F., Emery N., Maimaitiming S., Bellili N.,Travert F., Mohammedi K., Roussel R., Marre M., Fumeron F., Group D.S. Relationshipsbetween common polymorphisms of adenosine triphosphate-binding cassette transporterA1 and high-density lipoprotein cholesterol and coronary heart disease in a populationwith type 2 diabetes mellitus // Metabolism. 2009. Т.
58. № 1. — C. 74-9.130. Probst M.C., Thumann H., Aslanidis C., Langmann T., Buechler C., PatschW., Baralle F.E., Dallinga-Thie G.M., Geisel J., Keller C., Menys V.C., Schmitz G.Screening for functional sequence variations and mutations in ABCA1 // Atherosclerosis.2004. Т. 175. № 2. — C. 269-79.131. Pucci A., Formato L., Muscio M., Brscic E., Pizzimenti S., Ferroni F.,Ribezzo M., Toaldo C., Pettazzoni P., Ciamporcero E., Barrera G., Rinaldi M.,Bergamasco L., Sheiban I., Spinnler M.T. PPARgamma in coronary atherosclerosis: invivo expression pattern and correlations with hyperlipidemic status and statin treatment// Atherosclerosis.
2011. Т. 218. № 2. — C. 479-85.132. Qiao J.H., Tripathi J., Mishra N.K., Cai Y., Tripathi S., Wang X.P., Imes S.,Fishbein M.C., Clinton S.K., Libby P., Lusis A.J., Rajavashisth T.B. Role of macrophagecolony-stimulating factor in atherosclerosis: studies of osteopetrotic mice // Am J Pathol.1997. Т. 150.
№ 5. — C. 1687-99.109133. Quinet E.M., Savio D.A., Halpern A.R., Chen L., Miller C.P., Nambi P.Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor // J LipidRes. 2004. Т. 45. № 10. — C. 1929-42.134. Rader D.J. Molecular regulation of HDL metabolism and function:implications for novel therapies // J Clin Invest. 2006. Т. 116. № 12. — C.
3090-100.135. Rader D.J., Alexander E.T., Weibel G.L., Billheimer J., Rothblat G.H. Therole of reverse cholesterol transport in animals and humans and relationship toatherosclerosis // J Lipid Res. 2009. Т. 50 Suppl. — C. S189-94.136. Rader D.J., Pure E. Lipoproteins, macrophage function, and atherosclerosis:beyond the foam cell? // Cell Metab. 2005. Т. 1.
№ 4. — C. 223-30.137. Rao V.H., Kansal V., Stoupa S., Agrawal D.K. MMP-1 and MMP-9 regulateepidermal growth factor-dependent collagen loss in human carotid plaque smooth musclecells // Physiol Rep. 2014. Т. 2. № 2. — C. e00224.138. Rea P.A., Li Z.S., Lu Y.P., Drozdowicz Y.M., Martinoia E. From VacuolarGs-X Pumps to Multispecific Abc Transporters // Annu Rev Plant Physiol Plant Mol Biol.1998. Т. 49.
— C. 727-760.139. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B.,Heyman R.A., Dietschy J.M., Mangelsdorf D.J. Regulation of absorption and ABC1mediated efflux of cholesterol by RXR heterodimers // Science. 2000. Т. 289. № 5484.— C. 1524-9.140. Ricote M., Huang J., Fajas L., Li A., Welch J., Najib J., Witztum J.L.,Auwerx J., Palinski W., Glass C.K. Expression of the peroxisome proliferator-activatedreceptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophagesby colony stimulating factors and oxidized low density lipoprotein // Proc Natl Acad SciU S A. 1998.
Т. 95. № 13. — C. 7614-9.141. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., BordenW.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., HailpernS.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H.,Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S.,Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D.,110Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B., AmericanHeart Association Statistics C., Stroke Statistics S. Heart disease and stroke statistics-2012 update: a report from the American Heart Association // Circulation.
2012. Т. 125.№ 1. — C. e2-e220.142. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., Deleuze J.F.,Brewer H.B., Duverger N., Denefle P., Assmann G. Tangier disease is caused bymutations in the gene encoding ATP-binding cassette transporter 1 // Nat Genet. 1999. Т.22.
№ 4. — C. 352-5.143. Saleheen D., Khanum S., Haider S.R., Nazir A., Ahmad U., Khalid H.,Hussain I., Shuja F., Shahid K., Habib A., Frossard P.M. A novel haplotype in ABCA1gene effects plasma HDL-C concentration // Int J Cardiol. 2007. Т. 115. № 1. — C. 7-13.144. Schuster G.U., Parini P., Wang L., Alberti S., Steffensen K.R., HanssonG.K., Angelin B., Gustafsson J.A.
Accumulation of foam cells in liver X receptordeficient mice // Circulation. 2002. Т. 106. № 9. — C. 1147-53.145. Schwartz K., Lawn R.M., Wade D.P. ABC1 gene expression and ApoA-Imediated cholesterol efflux are regulated by LXR // Biochem Biophys Res Commun.2000. Т. 274. № 3. — C. 794-802.146. Seo D., Wang T., Dressman H., Herderick E.E., Iversen E.S., Dong C., VataK., Milano C.A., Rigat F., Pittman J., Nevins J.R., West M., Goldschmidt-Clermont P.J.Gene expression phenotypes of atherosclerosis // Arterioscler Thromb Vasc Biol.
2004.Т. 24. № 10. — C. 1922-7.147. Shchelkunova T.A., Morozov I.A., Rubtsov P.M., Bobryshev Y.V., SobeninI.A., Orekhov A.N., Andrianova I.V., Smirnov A.N. Lipid regulators duringatherogenesis: expression of LXR, PPAR, and SREBP mRNA in the human aorta // PLoSOne. 2013. Т. 8. № 5.
— C. e63374.148. Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J., Hayden M.R.Efflux and atherosclerosis: the clinical and biochemical impact of variations in theABCA1 gene // Arterioscler Thromb Vasc Biol. 2003. Т. 23. № 8. — C. 1322-32.149. Singaraja R.R., Fievet C., Castro G., James E.R., Hennuyer N., Clee S.M.,Bissada N., Choy J.C., Fruchart J.C., McManus B.M., Staels B., Hayden M.R.
Increased111ABCA1 activity protects against atherosclerosis // J Clin Invest. 2002. Т. 110. № 1. — C.35-42.150. Sivapalaratnam S., Basart H., Watkins N.A., Maiwald S., Rendon A.,Krishnan U., Sondermeijer B.M., Creemers E.E., Pinto-Sietsma S.J., Hovingh K.,Ouwehand W.H., Kastelein J.J., Goodall A.H., Trip M.D. Monocyte gene expressionsignature of patients with early onset coronary artery disease // PLoS One. 2012. Т.
7. №2. — C. e32166.151. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M.Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor(op) and apolipoprotein E // Proc Natl Acad Sci U S A. 1995. Т. 92. № 18. — C. 8264-8.152. Song C., Pedersen N.L., Reynolds C.A., Sabater-Lleal M., Kanoni S.,Willenborg C., Consortium C.A.D., Syvanen A.C., Watkins H., Hamsten A., Prince J.A.,Ingelsson E.
Genetic variants from lipid-related pathways and risk for incidentmyocardial infarction // PLoS One. 2013. Т. 8. № 3. — C. e60454.153. Soumian S., Gibbs R., Davies A., Albrecht C. mRNA expression of genesinvolved in lipid efflux and matrix degradation in occlusive and ectatic atheroscleroticdisease // J Clin Pathol. 2005. Т. 58.
№ 12. — C. 1255-60.154. Soumyarani V.S., Jayakumari N. Oxidatively modified high densitylipoprotein promotes inflammatory response in human monocytes-macrophages byenhanced production of ROS, TNF-alpha, MMP-9, and MMP-2 // Mol Cell Biochem.2012. Т. 366. № 1-2. — C. 277-85.155. Steffensen K.R., Gustafsson J.A. Putative metabolic effects of the liver Xreceptor (LXR) // Diabetes. 2004. Т. 53 Suppl 1. — C. S36-42.156. Sueyoshi S., Mitsumata M., Kusumi Y., Niihashi M., Esumi M., Yamada T.,Sakurai I. Increased expression of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR-gamma in human atherosclerosis // Pathol Res Pract.
2010. Т. 206. №7. — C. 429-38.157. Swirski F.K., Pittet M.J., Kircher M.F., Aikawa E., Jaffer F.A., Libby P.,Weissleder R. Monocyte accumulation in mouse atherogenesis is progressive and112proportional to extent of disease // Proc Natl Acad Sci U S A. 2006. Т. 103. № 27. — C.10340-5.158. Tabas I. Free cholesterol-induced cytotoxicity a possible contributing factorto macrophage foam cell necrosis in advanced atherosclerotic lesions // TrendsCardiovasc Med.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
